Why the study?
More evidence was required to establish the clinical impact and explanatory power of myocardial energy metabolite quantification by magnetic resonance spectroscopy compared to other diagnostic variables.
Does assessment of cardiac metabolism by MR spectroscopy improve the classification and understanding of cardiac changes in patients with obesity and diabetes?
Cross-Sectional (n=197)
No
Does assessment of cardiac metabolism by MR spectroscopy improve the classification and understanding of cardiac changes in patients with obesity and diabetes?
Cardiac metabolic parameters measured by MR spectroscopy (PCr/ATP and cardiac lipids) are stronger classifiers of obesity and diabetes than traditional global cardiac function metrics.
Answers are grounded in this paper and cite their sources.
Metabolic MR metrics may aid phenotyping in diabetes and obesity; hypothesis-generating pending prospective validation.
Recent developments in Magnetic resonance spectroscopy (MRS) techniques have demonstrated great potential for the quantification of myocardial energy metabolites, enabling an in-depth glimpse into the energetic state of the heart to better explain the onset and severity of disease states. However, more evidence is required to establish its clinical impact and explanatory power compared to other diagnostic variables. In this study, Random Forest classification was used on data from 197 subjects to discriminate between patients with and without diabetes and obesity using 31 P-MRS and 1 H-MRS measurements of cardiac energetics, along with MRI measures of cardiac function. Achieving 91.67%, 73.08% and 88.89% test accuracies, SHAP (SHapley Additive exPlanations) feature importances indicate a higher predictive impact of metabolic metrics for classifying the diabetic heart compared to global function metrics, gained through most common imaging techniques. Bayesian networks generated through structure learning of the data further suggests a potential causal association of increased visceral fat, increased LVMass resulting in decreased PCr/ATP, and increased cardiac lipid levels attributed to these disease states. Through the results, we have been able to showcase the importance of MRS measurements, both in distinguishing between diseases with clinically-relevant accuracy and furthermore its causal connection to other cardiac parameters.
No takes yet. Share an insight, caveat, or question.
Hanninger et al. (2023) conducted a cross-sectional in Obesity and Type 2 Diabetes Mellitus (n=197). Magnetic resonance spectroscopy (31P-MRS and 1H-MRS) was evaluated on Classification accuracy for patient subgroups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: